Cancer Vaccines Industry Research Report 2024: Market Poised for Exponential Growth with a Projected Value of $6.7 Billion by 2032
September 05, 2024 10:47 ET
|
Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Cancer Vaccines Market Report by Type,, Technology, Indication, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's...
Global Cancer Vaccine Market Research Report 2023: Synergistic Strategies - Combining Cancer Vaccines with Targeted Therapies for Enhanced Treatment Outcomes
July 17, 2023 06:38 ET
|
Research and Markets
Dublin, July 17, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Vaccine Market ,Vaccine Price, Dosage, Sales & Clinical Trials Outlook 2029" report has been added to ResearchAndMarkets.com's...
Global Cancer Vaccine Market & Clinical Trials Outlook 2028: Featuring Key Players AstraZeneca, BioNTech, Merck & Others
July 26, 2022 07:43 ET
|
Research and Markets
Dublin, July 26, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Vaccine Market & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The global cancer...
Global Cancer Vaccine Markets to 2026: Approvals for Additional Indications, Competition, Increased Funding, Manufacturers' Strategies, Challenges in Cancer Vaccines
August 13, 2021 06:33 ET
|
Research and Markets
Dublin, Aug. 13, 2021 (GLOBE NEWSWIRE) -- The "Cancer Vaccines: Technologies and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for cancer...